Caroline Kant, Co-founder and Executive Director, will participate as a panelist at the Seventy-Ninth World Health Assembly Side Event on Precision Medicine, taking place on 19 May 2026 at the Permanent Mission of Egypt in Geneva.
Convened under the theme “From Innovation to Impact: Advancing Precision Medicine for Universal Health Coverage and Health Equity,” the side event will bring together Ministries of Health, WHO representatives, academic institutions, private sector leaders, civil society, and patient advocates to discuss how precision medicine can be integrated equitably and sustainably into health systems.
Caroline will contribute to the panel discussion “From Discovery to Delivery: Translating Genomics and Innovation into Equitable and Inclusive Precision Medicine.” Her intervention will focus on rare diseases, global collaboration, and the role of innovative partnerships in advancing equitable precision medicine, drawing on EspeRare’s experience in translating cutting-edge scientific advances into accessible therapeutic opportunities for patients with high unmet medical needs.
She will also highlight EspeRare’s collaboration with n-Lorem Foundation, as an example of how partnerships can help accelerate the access of highly individualized therapeutic approaches for people living with ultra-rare diseases.
The discussion will explore practical pathways to move precision medicine from scientific promise to measurable health impact, including sustainable access frameworks, early diagnosis, targeted interventions, and patient-centered implementation.
Through this participation, EspeRare will emphasize the importance of ensuring that precision medicine benefits underserved populations, including people living with rare diseases, while supporting the broader goals of Universal Health Coverage and health equity.
